Community Connect: Shared responsibility in caring for the person with pain

You are cordially invited to participate in Community Connect, a meeting of local prescribers and pharmacists to provide perspectives about shared responsibilities in prescribing and dispensing prescription opioid pain medications. These meetings will provide an environment in which participants may collaborate to better serve their patients with pain and will feature a panel of thought […]

SPPAN convenes fifteen patient advocacy organizations to discuss collective action

In an unprecedented effort to collaborate, innovate, and effect change through collective action, fifteen patient and consumer advocacy groups convened in Nashville, Tennessee in March 2014.  The meeting, which was moderated by the State Pain Policy Advocacy Network, a project of the American Academy of Pain Management, was the first step in discussing common ground […]

Bob Twillman receives award for ‘Excellence in Editorial Writing’ from the Federation of State Medical Boards

 For Immediate Release: April 11, 2014 Contact: Drew Carlson, (817) 868-4043 dcarlson@fsmb.org; www.fsmb.org Federation of State Medical Boards Announces Annual Award Winners EULESS, Texas (April 11, 2014) – The Federation of State Medical Boards (FSMB) announced the recipients of its 2014 awards recognizing outstanding service and leadership in the field of medical regulation. The awards […]

American Academy of Pain Management releases statement on extended-release hydrocodone

American Academy of Pain Management Statement on Extended-Release Hydrocodone (ZohydroTM ER) April 8, 2014 In October, 2013, the US Food and Drug Administration (FDA) approved ZohydroTM ER, the first single-agent extended release hydrocodone product to enter the US market. This approval came despite an FDA advisory committee vote recommending non-approval, based on the fact that […]

FDA approves St. Jude Medical’s Protégé spinal cord stimulator

Excerpt: St. Jude Medical, a global medical device company, today announced the approval of its Protégé™ IPG from the U.S. Food and Drug Administration (FDA). Protégé is the first and only neurostimulation system that allows spinal cord stimulation (SCS) technology upgrades as they are approved to be made via software updates. Chronic pain sufferers implanted […]